How many analysts have analysed BLUEJAY DIAGNOSTICS INC (BJDX)?
The number of analysts covering BLUEJAY DIAGNOSTICS INC (BJDX) is 6.
NASDAQ:BJDX • US0956336087
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for BLUEJAY DIAGNOSTICS INC (BJDX).
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2023-08-03 | Dawson James | Downgrade | Buy -> Neutral |
| 2022-01-12 | Dawson James | Initiate | Buy |
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | ||
|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 250K | -100.00% | 5.155M | 8.019M 55.56% | ||||
| EBITDA YoY % growth | -1.04M 30.20% | -3.09M -197.12% | -9.16M -196.44% | N/A -5.49% | N/A 26.58% | N/A | N/A | |
| EBIT YoY % growth | -1.2M 26.38% | -3.24M -170.00% | -9.32M -187.65% | -9.673M -10.64% | -9.135M 30.47% | -8.223M -14.70% | -8.289M -0.79% | |
| Operating Margin | N/A | N/A | -3,728.00% | N/A | N/A | -159.52% | -103.36% | |
| EPS YoY % growth | N/A | N/A | -3,760.00 45.14% | -7,980.48 3.30% | -1.01 99.97% | -0.33 67.68% | -0.30 9.38% |
All data in USD
| EPS Q2Q % growth |
|---|
| Revenue Q2Q % growth |
| EBITDA Q2Q % growth |
| EBIT Q2Q % growth |
All data in USD
The number of analysts covering BLUEJAY DIAGNOSTICS INC (BJDX) is 6.